Gainers
-
Regional Health Properties Inc (NYSE: RHE) climbed 85.6 percent to $2.32 after the company entered a new forbearance
agreement with Pinecone Realty Partners.
-
Amira Nature Foods Ltd. (NYSE: ANFI)
gained 32.7 percent to $0.5840.
-
Axsome Therapeutics, Inc. (NASDAQ: AXSM) surged 26 percent to $8.65 on continued strength after the company on
Monday announced its Phase 2 trial of AXS-05 in major depressive order met its primary endpoint. Axsome Therapeutics raised
$23.3 million under existing at-the-market facility.
-
Tactile Systems Technology, Inc. (NASDAQ: TCMD) rose 25.1 percent to $59.23 after the company issued Q4 and FY18 sales
guidance above analyst estimates.
-
HopFed Bancorp, Inc. (NASDAQ: HFBC)
shares climbed 24.5 percent to $18.67 after the company agreed to a $128.3 million takeover by First Financial.
-
CLPS Incorporation (NASDAQ: CLPS)
shares rose 24.3 percent to $3.8601.
-
Phunware Inc. (NASDAQ: PHUN) gained 21
percent to $75.00.
-
Dunxin Financial Holdings Limited (NYSE: DXF) shares surged 14.7 percent to $2.34.
-
Hexindai Inc. (NASDAQ: HX) rose 11.1
percent to $3.00. Hexindai acquired a 5.88 percent stake in Phoenix Intelligent Credit Group Ltd for $29 million.
-
Motorcar Parts of America, Inc. (NASDAQ: MPAA) shares gained 10.7 percent to $21.17 after the company beat Q2 sales
estimates and reported year-over-year EPS growth.
-
Celyad SA (NASDAQ: CYAD) rose 10.7
percent to $24.58.
-
scPharmaceuticals Inc. (NASDAQ: SCPH)
rose 9.8 percent to $3.70.
-
Adient plc (NYSE: ADNT) gained 9.8
percent to $17.97.
-
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) surged 9.6 percent to $8.25.
-
Key Energy Services, Inc. (NYSE: KEG)
gained 9.4 percent to $2.67.
-
Union Pacific Corporation (NYSE: UNP)
rose 9.3 percent to $151.50 after the company named Jim Vena as new COO. Scotiabank upgraded Union Pacific from Sector Perform
to Outperform.
-
Molina Healthcare, Inc. (NYSE: MOH)
gained 8.5 percent to $127.77 after JP Morgan upgraded the company's stock from Neutral to Overweight and raised its price
target from $127 per share to $150 per share.
-
vTv Therapeutics Inc. (NASDAQ: VTVT)
climbed 8.1 percent to $2.5601.
-
Mirati Therapeutics, Inc. (NASDAQ: MRTX) gained 7.1 percent to $51.69.
-
Marin Software Incorporated (NASDAQ: MRIN) gained 6.4 percent to $5.85.
-
Veoneer, Inc. (NYSE: VNE) rose 5.5
percent to $27.98 after the company disclosed that it has achieved record full year order intake.
-
Monster Beverage Corp (NASDAQ: MNST)
gained 5.5 percent to $52.46 after Suntrust Robinson Humphrey upgraded the stock from Hold to Buy and raised its price target
from $50 per share to $65 per share.
Check out these big penny stock gainers and
losers
Losers
-
Maxar Technologies Ltd. (NYSE: MAXR)
shares dipped 35 percent to $5.22. Maxar Technologies dropped 31.48 percent on Monday after the company reported failure of its
WorldView-4 Satellite. Credit Suisse downgraded Maxar Technologies from Neutral to Underperform.
-
AudioEye, Inc. (NASDAQ: AEYE) shares
dipped 15.2 percent to $7.55.
-
Helen of Troy Limited (NASDAQ: HELE)
fell 13.1 percent to $115.65. Helen of Troy reported better-than-expected results for its third quarter, but lowered its
full-year sales forecast.
-
Leap Therapeutics, Inc. (NASDAQ: LPTX)
dropped 12.6 percent to $2.63.
-
Inpixon (NASDAQ: INPX) shares fell
10.5 percent to $3.33.
-
Smaaash Entertainment Inc. (NASDAQ: SMSH) fell 10.2 percent to $1.8090.
-
First Financial Corporation (NASDAQ: THFF) dipped 9.7 percent to $38.41. First Financial and HopFed Bancorp signed
a merger agreement.
-
Cidara Therapeutics, Inc. (NASDAQ: CDTX) dropped 9.2 percent to $2.97.
-
PG&E Corporation (NYSE: PCG) fell 8.6
percent to $17.32 after S&P Global lowered the rating on PG&E and its Pacific Power & Gas Co unit to "B" from "BBB-" on
announced board review.
-
Meridian Bioscience, Inc. (NASDAQ: VIVO) shares dipped 8.2 percent to $15.21. Meridian Bioscience expects a 2
percent year-over-year drop in Q'19 revenues to $51 million to $51.5 million, weighed down by weakness in Diagnostics segment.
This is below the $53.5 billion consensus estimate.
-
UroGen Pharma Ltd. (NASDAQ: URGN)
dropped 8 percent to $50.19 after reporting results of UGN-101 from pivotal Phase 3 OLYMPUS trial for the non-surgical
treatment of patients with low-grade upper tract urothelial cancer.
-
Charah Solutions, Inc. (NYSE: CHRA)
declined 7.1 percent to $7.59.
-
Weibo Corporation (NASDAQ: WB) fell 6.4
percent to $58.65 after rising 2.29 percent on Monday.
-
NRC Group Holdings Corp. (NYSE: NRCG)
shares dropped 6.1 percent to $7.52.
-
Illumina, Inc. (NASDAQ: ILMN) dropped
6 percent to $289.40.
-
SunPower Corporation (NASDAQ: SPWR)
shares fell 4.5 percent to $5.23. Barclays initiated coverage on SunPower with an Underweight rating.
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.